1
MODULE 7 DISCUSSION
Describe the KEY POINT and how the knowledge of the chosen Key Point impacts
the care provided by the Nurse Practitioner.
PARKINSON’S DISEASE AND BRAIN MICROTRAUMA / CONCUSSION
Parkinson’s Disease (PD) is known to be a progressive, multi system
neurodegenerative disease affecting people as they grow older. It is the second most
common neurodegenerative disease globally with increasing incidence and prevalence
along with the changing population demographics (Pringsheim et al, 2014).
In Parkinson’s Disease, the dopamine levels are decreased, which results in
dopaminergic cell death, which is then manifested by motor deficiency and, possibly, a
reason of the cognitive deficit noted in some PD patients. PD is generally not recognized in
its early stage because of a long latency between the first damage to dopaminergic cells
and the onset of clinical symptoms. There are potential risk factors such as environmental
toxins, drugs, pesticides, brain microtrauma, focal cerebrovascular damage, and genomic
defects (Emamzadeh & Surguchov, 2018).
The Key Point that will be discussed is BRAIN MICROTRAUMA or CONCUSSION.
Muhammad Ali, the famous boxer who had a successful boxing career and was diagnosed
with Parkinson’s disease that eventually succumbed to it at the age of 74 in 2016, comes to
the this student’s mind when Parkinson’s Disease and the risk factor of concussion is talked
about (Tedeshi, 2016). Concussion is described as a traumatically induced disturbance of
brain function involving a complex pathophysiological process. It is a major concern in a
number of contact collision sports. Multiple concussions can be referred to as Cumulative
This study source was downloaded by 100000806176105 from CourseHero.com on 04-10-2022 00:43:49 GMT -05:00
https://www.coursehero.com/file/79585166/NURS-5315-M7-DISCUSSION-BOARDdocx/
MODULE 7 DISCUSSION
Describe the KEY POINT and how the knowledge of the chosen Key Point impacts
the care provided by the Nurse Practitioner.
PARKINSON’S DISEASE AND BRAIN MICROTRAUMA / CONCUSSION
Parkinson’s Disease (PD) is known to be a progressive, multi system
neurodegenerative disease affecting people as they grow older. It is the second most
common neurodegenerative disease globally with increasing incidence and prevalence
along with the changing population demographics (Pringsheim et al, 2014).
In Parkinson’s Disease, the dopamine levels are decreased, which results in
dopaminergic cell death, which is then manifested by motor deficiency and, possibly, a
reason of the cognitive deficit noted in some PD patients. PD is generally not recognized in
its early stage because of a long latency between the first damage to dopaminergic cells
and the onset of clinical symptoms. There are potential risk factors such as environmental
toxins, drugs, pesticides, brain microtrauma, focal cerebrovascular damage, and genomic
defects (Emamzadeh & Surguchov, 2018).
The Key Point that will be discussed is BRAIN MICROTRAUMA or CONCUSSION.
Muhammad Ali, the famous boxer who had a successful boxing career and was diagnosed
with Parkinson’s disease that eventually succumbed to it at the age of 74 in 2016, comes to
the this student’s mind when Parkinson’s Disease and the risk factor of concussion is talked
about (Tedeshi, 2016). Concussion is described as a traumatically induced disturbance of
brain function involving a complex pathophysiological process. It is a major concern in a
number of contact collision sports. Multiple concussions can be referred to as Cumulative
This study source was downloaded by 100000806176105 from CourseHero.com on 04-10-2022 00:43:49 GMT -05:00
https://www.coursehero.com/file/79585166/NURS-5315-M7-DISCUSSION-BOARDdocx/
